Koji Ebisumoto

Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification

Soichiro Takase, Satoshi Kano, Yuichiro Tada et al. · Oncotarget · 2017 · 110 citations · Full text

Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation

Chao Liu, Sayed H. Sadat, Koji Ebisumoto et al. · Clinical Cancer Research · 2020 · 75 citations · Full text

Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas

Tomotaka Shimura, Yuichiro Tada, Hideaki Hirai et al. · Oncotarget · 2017 · 49 citations · Full text

A new technique to expose the hypopharyngeal space: The Modified Killian's method

Akihiro Sakai, Kenji Okami, Ryousuke Sugimoto et al. · Auris Nasus Larynx · 2013 · 48 citations

New Technique, Modified Killian, Hypopharyngeal Space

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi et al. · Therapeutic Advances in Medical Oncology · 2022 · 40 citations · Full text